Pinilla-Ibarz J - Search Results

1

Venous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphoma.

Hashmi H, Mirza AS, Darwin A, Logothetis C, Garcia F, Kommalapati A, Mhaskar RS, Bachmeier C, Chavez JC, Shah B, Pinilla-Ibarz J, Khimani F, Lazaryan A, Liu H, Davila ML, Locke FL, Nishihori T, Jain MD. Hashmi H, et al. Blood Adv. 2020 Sep 8;4(17):4086-4090. doi: 10.1182/bloodadvances.2020002060. Blood Adv. 2020. PMID: 32877523 Free PMC article.

2

Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia.

Kharfan-Dabaja MA, Chavez JC, Khorfan KA, Pinilla-Ibarz J. Kharfan-Dabaja MA, et al. Cancer. 2008 Sep 1;113(5):897-906. doi: 10.1002/cncr.23671. Cancer. 2008. PMID: 18618518 Free article. Review.

3

The biological basis for immunotherapy in patients with chronic myelogenous leukemia.

Pinilla-Ibarz J, Shah B, Dubovsky JA. Pinilla-Ibarz J, et al. Cancer Control. 2009 Apr;16(2):141-52. doi: 10.1177/107327480901600206. Cancer Control. 2009. PMID: 19337200 Free article. Review.

4

Stat3 inhibition augments the immunogenicity of B-cell lymphoma cells, leading to effective antitumor immunity.

Cheng F, Wang H, Horna P, Wang Z, Shah B, Sahakian E, Woan KV, Villagra A, Pinilla-Ibarz J, Sebti S, Smith M, Tao J, Sotomayor EM. Cheng F, et al. Cancer Res. 2012 Sep 1;72(17):4440-8. doi: 10.1158/0008-5472.CAN-11-3619. Epub 2012 Jun 22. Cancer Res. 2012. PMID: 22728650 Free PMC article.

5

Phase II study of CD4+-guided pentostatin lymphodepletion and pharmacokinetically targeted busulfan as conditioning for hematopoietic cell allografting.

Kharfan-Dabaja MA, Anasetti C, Fernandez HF, Perkins J, Ochoa-Bayona JL, Pidala J, Perez LE, Ayala E, Field T, Alsina M, Nishihori T, Locke F, Pinilla-Ibarz J, Tomblyn M. Kharfan-Dabaja MA, et al. Biol Blood Marrow Transplant. 2013 Jul;19(7):1087-93. doi: 10.1016/j.bbmt.2013.04.020. Epub 2013 Apr 28. Biol Blood Marrow Transplant. 2013. PMID: 23632090 Free PMC article. Clinical Trial.

6

Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemia.

Chavez JC, Sahakian E, Pinilla-Ibarz J. Chavez JC, et al. Core Evid. 2013;8:37-45. doi: 10.2147/CE.S34068. Epub 2013 May 16. Core Evid. 2013. PMID: 23717217 Free PMC article.

7

Genomic aberrations deletion 11q and deletion 17p independently predict for worse progression-free and overall survival after allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia.

Chavez JC, Kharfan-Dabaja MA, Kim J, Yue B, Dalia S, Pinilla-Ibarz J, Anasetti C, Locke FL. Chavez JC, et al. Leuk Res. 2014 Oct;38(10):1165-72. doi: 10.1016/j.leukres.2014.04.006. Epub 2014 Apr 28. Leuk Res. 2014. PMID: 24889511 Free PMC article.

8

Life after ibrutinib? A new unmet need in CLL.

Pinilla-Ibarz J, Chavez JC. Pinilla-Ibarz J, et al. Blood. 2015 Mar 26;125(13):2013-4. doi: 10.1182/blood-2015-02-622472. Blood. 2015. PMID: 25814485 Free article.

9

An update on current and prospective immunotherapies for chronic lymphocytic leukemia.

Emole JN, Locke FL, Pinilla-Ibarz J. Emole JN, et al. Immunotherapy. 2015;7(4):455-66. doi: 10.2217/imt.15.14. Immunotherapy. 2015. PMID: 25917633 Review.

10

Second Myeloid Malignancies in a Large Cohort of Patients With Chronic Lymphocytic Leukemia: A Single Institution Experience.

Chavez JC, Dalia S, Sandoval-Sus J, Kharfan-Dabaja MA, Al-Ali N, Komrokji R, Padron E, Corrales-Yepez G, Rock-Klotz J, Pinilla-Ibarz J. Chavez JC, et al. Clin Lymphoma Myeloma Leuk. 2015 Jun;15 Suppl:S14-8. doi: 10.1016/j.clml.2015.03.013. Clin Lymphoma Myeloma Leuk. 2015. PMID: 26297266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page